1616 results
Contemporary TAVI cases: perspectives from three different continents
16 May 2024 – From EuroPCR 2024
This session provides perspectives from three different continents on the management of complex TAVI cases. It features case presentations and discussions on topics such as TAVR for the correction of aortic pseudoaneurysm, TAV-in-TAV intervention, and the management of aortic stenosis in patients with hypertrophic obstructive cardiomyopathy....
New data on TAVI
16 May 2024 – From EuroPCR 2024
This session presents the latest research and data on transcatheter aortic valve implantation (TAVI). It covers a range of topics, including long-term results of TAVI versus surgical aortic valve replacement in low-risk severe aortic stenosis, real-world experience with novel transcatheter heart valve devices, outcomes in patients...
TAVI: when calcifications are the major issues
16 May 2024 – From EuroPCR 2024
This session explores various challenging TAVI cases where severe aortic valve calcification was the main obstacle. Presenters share their experiences and strategies in overcoming these complex anatomical issues, including the use of techniques like the buddy balloon technique, snare technique, and innovative approaches to cross the...
TAVI indications: real dilemmas
16 May 2024 – From EuroPCR 2024
This session comprises selected clinical case submissions that explore real-world dilemmas and challenges faced by interventional cardiologists in TAVI procedures. Participants will delve into discussions on topics such as left bundle branch area pacing after TAVR, challenges in TAVI, simultaneous CardioFlow Optimisation, coronary access post-TAVI, complex...
TAVI: procedural complications - Part 2
16 May 2024 – From EuroPCR 2024
This session focuses on the management of procedural complications during transcatheter aortic valve implantation (TAVI). It presents a series of challenging cases, including valve-in-valve TAVI with complications, acute cardiogenic shock during valve-in-valve TAVI, and various other complications such as left ventricular perforation, fistula formation, and lost...
Abstracts from the Call for submissions - Nurses and Allied Professionals
16 May 2024 – From EuroPCR 2024
This session features selected abstracts from the call for submissions, focusing on the contributions of nurses and allied health professionals in the field of interventional cardiology. The presentations cover topics such as patient experience in the TAVI process, insights into the use of intravascular imaging and...
REC-CAGEFREE II, NOTION-2, LANDMARK: Three major late-breaking trials presented at EuroPCR 2024
15 May 2024
The Course Directors have selected 3 major Late Breaking Trials (LBTs) that were presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice.
Major Late-Breaking Trials from EuroPCR 2024
15 May 2024 – From EuroPCR 2024
This session presents the latest results from major late-breaking trials presented at EuroPCR 2024. It covers a one-month DAPT followed by 5-month ticagrelor monotherapy in acute coronary syndromes with DCB, the first TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid...
Aortic valve-in-valve or TAV-in-TAV challenges
15 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the challenges of aortic valve-in-valve or TAV-in-TAV procedures. The session will feature various complex cases, including when even two surgeries are not enough, resilient rhythms in geriatric resurgence, valve-in-valve TAVI for degenerated small surgical bioprosthetic...
Management of multiple valve disease
15 May 2024 – From EuroPCR 2024
Valve-in-valve: utility of splitting devices
15 May 2024 – From EuroPCR 2024
This session focuses on the use of specialized splitting devices for transcatheter aortic valve-in-valve procedures. It features a case series demonstrating the application of a dedicated splitting device in failed TAVI valves, as well as the use of the BASILICA technique for transcatheter aortic valve replacement....
LANDMARK RCT - Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
15 May 2024 – From EuroPCR 2024
This session provides an overview of the early outcomes of the LANDMARK trial, a randomized non-inferiority trial comparing TAVI devices. It examines baseline characteristics, the significance of intermediate sizes according to MSCT recommendations, real-world representative cases from the LANDMARK RCT, insights from quantitative aortography and echocardiography...
Contemporary TAVI: the VISION of lifetime management
15 May 2024 – From EuroPCR 2024
In this session, discover how pre-procedural assessment is used to optimize procedural outcomes, ensuring the best possible results for patients undergoing TAVI, learn the intricacies of selecting the most suitable valve for each individual patient, considering their unique anatomical and clinical factors, and engage in discussions...
How does the female heart respond to severe aortic stenosis and aortic intervention?
15 May 2024 – From EuroPCR 2024
In this session, gain insights into the gender-specific differences among patients with aortic stenosis (AS) and their implications for treatment strategies. Explore the significance of hemodynamics and durability from a patient's perspective, shedding light on the importance of personalized care. Engage in discussions about the optimal...
Planning for a lifetime starts with choosing the right valve first: from first TAVI to redo-TAVI
15 May 2024 – From EuroPCR 2024
Watch this session to learn the best practices for treating aortic stenosis, with a focus on lifetime management. Gain insights into evaluating patient anatomy and clinical presentation to anticipate the need for a second valve, understand different valve designs and their initial selection, and observe a...
Innovation and strategies in TAVI: design, data and directions for clinical practice
15 May 2024 – From EuroPCR 2024
Watch this session to explore considerations for TAVI implantation in small annuli, gain insights into future lifetime management, learn about the benefits of FX technology and clinical evidence beyond small annuli, and witness a live case procedure showcasing the innovation of FX plus. This session is...
Align for the future with next-generation balloon expandable THV technology
15 May 2024 – From EuroPCR 2024
In this session, explore the next-generation balloon-expandable Myval Octacor THV, focusing on its key features, procedural impact, and potential clinical benefits. Understand the procedural steps for planning and implanting it, especially for intermediate and extra-large sizes, using the Octalign technique. Learn about the unmet clinical need...
TAVI: new devices, original solutions for procedural complications
15 May 2024 – From EuroPCR 2024
Complex scenarios beyond complex interventions, time to take multiple factors into account
15 May 2024 – From EuroPCR 2024
TAVI in cardiogenic shock
15 May 2024 – From EuroPCR 2024
